Cargando…
Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges
Acute myeloid leukemia (AML) is a malignant blood disorder and the cure rate has been remarkably improved over the past decade. However, recurrent or refractory leu-kemia remains the major problem of the AML and no clearly effective therapy has been es-tablished so far. Traditional treatments such a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302345/ https://www.ncbi.nlm.nih.gov/pubmed/28671056 http://dx.doi.org/10.2174/1381612823666170703164114 |